Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine

Froes, F.; Timóteo, A.; Almeida, B.; Raposo, J.F.; Oliveira, J.; Carrageta, M.; Duque, S.; Morais, A.

doi:10.1016/j.pulmoe.2023.11.003

Cited by 2 publications

(4 citation statements)

References 126 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Receiving PSV23 was inadequate for protecting the patients from developing these adverse outcomes, while PCV13 alone can prevent all-cause mortality and respiratory-related mortality, but not the development of secondary bacterial pneumonia. The results concur with previously reported benefits from pneumococcal vaccines among patients with chronic airway diseases, reinforcing the need for adequate vaccination coverage among these high-risk patients before influenza outbreaks [10,11,21].…”

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study

Kwok,

Lung,

Tam

et al. 2024

Vaccines

View full text Add to dashboard Cite

Influenza is an important respiratory viral pathogen in adults, with secondary bacterial pneumonia being a common complication. While pneumococcal vaccines can prevent pneumococcal pneumonia and invasive pneumococcal disease, whether they can also prevent the severe in-hospital outcomes among patients hospitalized for influenza has not been examined. A territory-wide retrospective study was conducted in Hong Kong, which included all adult patients having chronic airway diseases (asthma, bronchiectasis, and chronic obstructive pulmonary disease) hospitalized for influenza and who had received seasonal influenza vaccine. The occurrence of secondary bacterial pneumonia, mortality, and other severe in-hospital outcomes were compared among subjects with or without pneumococcal vaccination. There was a total of 3066 eligible patients who were hospitalized for influenza in public hospitals in Hong Kong from 1 January 2016 to 30 June 2023. Completed pneumococcal vaccination with PSV23/PCV13 conferred protection against secondary bacterial pneumonia, all-cause mortality, and respiratory cause of mortality with adjusted odds ratios of 0.74 (95% CI = 0.57–0.95, p = 0.019), 0.12 (95% CI = 0.03–0.53, p = 0.005), and 0.04 (95% CI = 0.00–0.527, p = 0.0038), respectively.

show abstract

Section: Discussionsupporting

confidence: 90%

“…Patients with chronic respiratory diseases, including but not limited to asthma, bronchiectasis, and COPD, are at risk of severe influenza and are recommended to receive influenza as well as pneumococcal vaccines [10][11][12].…”

Section: Introductionmentioning

confidence: 99%

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study

Kwok,

Lung,

Tam

et al. 2024

Vaccines

View full text Add to dashboard Cite

show abstract

“…Previous research has observed that RSV is often not diagnosed in adults with influenza-like illness [44]. This phenomenon has also been noted for other respiratory viruses, such as the influenza virus, where high rates of unrecognized cases persist [45,46]. A third of the interviewed cardiac HCWs believed that one possible reason for this underdiagnosis is the lack of specific treatment for RSV infection, as previously reported in a similar study conducted among primary care physicians in the US [33].…”

Section: Discussionsupporting

confidence: 63%

Section: Discussionmentioning

confidence: 68%

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

Ponticelli,

Losa,

Antonazzo

et al. 2024

Infectious Disease Reports

View full text Add to dashboard Cite

As respiratory syncytial virus (RSV) vaccine distribution gains traction in Europe and Italy, healthcare workers (HCWs) can strategize about vaccine promotion to increase uptake among patients at risk of RSV consequences, such cardiac patients. This cross-sectional survey investigated the knowledge about and attitude towards RSV and RSV vaccines, and the intention to recommend vaccination within a cardiological hospital in Italy. To explore factors associated with the outcomes of interest, multivariate logistic regression analyses were conducted. Of 197 invited HCWs, 78.2% returned the survey. The knowledge about market authorisation for new RSV vaccines for older adults (present in 46.9% of respondents) was significantly associated with the HCWs’ age, education, and previous update on vaccinations. HCWs with a higher educational level and those with a positive attitude towards RSV vaccines safety reported a higher attitude towards the importance of vaccinating people at risk. The willingness of recommending RSV vaccination to patients (70.5% of respondents) was more likely in HCWs who were knowledgeable about market authorisation for RSV vaccines and in physicians. This tempestive research sheds light on current factors influencing the strategies of cardiac HCWs regarding RSV vaccination. The results suggest the need for training events on the protective role of RSV vaccination in cardiac patients.

show abstract

Cited by 2 publications

References 126 publications

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

Contact Info

Product

Resources

About